Eli Lilly and Company Logo

Eli Lilly and Company (LLY)

BMV

Currency in MXN
20,969.00
+263.99 (+1.28%)

Closed

Oct 6, 2026

Day's Range

20,969.00
20,969.00

52 wk Range

14,600.00
21,925.29

Profile - LLY - Eli Lilly and Company

Profile

Mic Code

XMEX

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

50K


Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular care, serving patients, healthcare providers, and health systems worldwide. Its current portfolio includes widely used treatments for chronic metabolic conditions as well as therapies for cancer and immune-related diseases, supported by ongoing commercial operations and regulated manufacturing capacity in the United States, Europe, and Asia. The company also advances diagnostics and specialty medicines that address complex medical needs in hospital, outpatient, and community settings. Eli Lilly and Company plays a significant role in the pharmaceutical market through its broad product lineup, large-scale distribution network, and focus on prescription medicines that are used in everyday clinical practice.

Profile Details

Type

Common Stock

Address

Lilly Corporate Center

City

Indianapolis

State

IN

Zip

46285

Country

United States

Phone

317 276 2000

Key Executives - LLY - Eli Lilly and Company

Key executives

NamePositionAgePay
Mr. David A. RicksChairman, President & CEO57153.85M
Mr. Donald A. ZakrowskiSenior VP of Finance & Chief Accounting Officer--
Mr. Eric DozierExecutive VP & Chief People Officer58-
Mr. Ilya YuffaExecutive VP and President of Lilly USA & Global Customer Capabilities50-
Mr. Michael CzaparSenior Vice President of Investor Relations--
Dr. Daniel M. Skovronsky M.D., Ph.D.Chief Scientific & Product Officer and President of Lilly Research Laboratories5284.47M
Ms. Anat Hakim J.D.Executive VP, General Counsel & Secretary5657.64M
Mr. Lucas E. MontarceExecutive VP & CFO4855.87M
Mr. Jacob S. Van NaardenExecutive VP, President of Lilly Oncology & Head of Corporate Business Development4051.71M
Mr. Diogo RauExecutive VP and Chief Information & Digital Officer5018.22M

Cross Listings - LLY - Eli Lilly and Company

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.